Medical Device Fund

University of Wollongong biomedical engineer Dr Robert Gorkin said researchers are redefining what the condom could be.
University of Wollongong biomedical engineer Dr Robert Gorkin said researchers are redefining what the condom could be.

Wollongong researchers have won a $1 million grant to further develop and market a next-generation, non-allergenic condom and take it to human trials.

Eudaemon Technologies was one of seven companies to share in $9.85 million in state government grants under the 2018 NSW Medical Devices Fund (MDF).

Eudaemon Technologies hopes its condom will be on the market within two years, with the grant enabling researchers to launch a human trial by the end of 2018.

“We are redefining what the condom could be,” University of Wollongong biomedical engineer Dr Robert Gorkin said.

“There are 1 million new STIs diagnosed every day, 80 million unplanned pregnancies per year, a $60 billion global burden and the biggest issue for condoms is feel.

The next-generation condom being developed in Wollongong.

The next-generation condom being developed in Wollongong.

“Our product is designed to overcome the No 1 issue with condoms because ultimately the choice of using this medical device is up to the consumer.”

NSW Health Minister Brad Hazzard said since the MDF began in 2013, more than $50 million in grants had been awarded to 31 technologies. 

- with smh.com.au